Lisa Diamond is a member of the research faculty of the Immigrant Health and Cancer Disparities Service, which facilitates linguistically and culturally sensitive health care services for newcomer populations through research, education, training, program development, policy, and advocacy. Her research focuses on understanding how clinician non-English language proficiency affects the quality of care delivered to patients with limited English proficiency (LEP). Ultimately, she plans to use the results of her research to establish standards for the appropriate use of non-fluent non-English language skills by clinicians and to identify process and outcome measures that capture the quality of cancer care being delivered to LEP patients.
Prior to joining Memorial-Sloan Kettering Cancer Center, Dr. Diamond was a Research Physician and Hospitalist at the Palo Alto Medical Foundation Research Institute. Her research there included a study funded by The California Endowment to identify better methods for measuring clinician non-English language proficiency and determine physician, patient, and system factors that help explain race/ethnic and language-related disparities in care.
Dr. Diamond is a board-certified internist, focusing on inpatient hospital medicine. She completed medical school at the George Washington University School of Medicine and has a Master of Public Health (MPH) degree from the Johns Hopkins Bloomberg School of Public Health. She completed her Internal Medicine residency at New York Presbyterian/Columbia University Medical Center, followed by a fellowship in the Robert Wood Johnson Clinical Scholars Program at Yale University, and a postdoctoral fellowship at the Philip R. Lee Institute for Health Policy Studies at the University of California, San Francisco.
- Clinical Expertise: Internal Medicine; Immigrant Health
- Languages Spoken: English
- Education: MD, George Washington University School of Medicine; MPH, Johns Hopkins Bloomberg School of Public Health; MHS, Yale University School of Medicine
- Residencies: NewYork-Presbyterian Hospital/Columbia University Medical Center
- Fellowships: Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine
- Board Certifications: Internal Medicine
Stults, C.D., Lafata, J. E., Diamond, L.C., MacLean, L., Stone, A.L., Wunderlich, T., Frankel, R.M., and Tai-Seale, M. How Do Primary Care Physicians Respond When Patients Cry During Routine Ambulatory Visits? Journal of Communication in Healthcare. In press 2014.
Diamond L.C., Chung S., Ferguson W., Gonzalez J., Jacobs E.A., Gany F. Relationship between Self-Assessed and Tested Non-English Language Proficiency among Primary Care Providers. Medical Care, 2014;Epub Ahead-of-Print.
Gany F, Diamond L.C., Meislin R, Gonzalez J. Ensuring Access to Research for Non-Dominant Language Speakers. In: Schenker M, Castenada X, Lainz AR, eds. Migration and Health: Research Methods Handbook: University of California Press; In Press 2013.
Gany, F., Yogendran, L., Massie, D., Ramirez, J., Lee, T., Winkel, G., Diamond, L.C., Leng, J. “Doctor, what do I have?” Knowledge of cancer diagnosis among immigrant/migrant minorities. J Cancer Educ, 2013; 28(1):165-70.
Tai-Seale, M., Lafata, J.E., Wunderlich, T., MacLean, L., Diamond, L.C. PS2-17: What Happens When Adult Patients Cry in Primary Care Visits? Journal of Clinical Medicine Research, 2012; 10(3): 180.
Diamond, L.C., Moreno, M., Otero-Sabogal, R. Bilingual Dual-Role Staff Interpreters – Factors Associated with Passing a Language Competency Test. International Journal of Interpreter Education, 2012; 4(1): 5 – 20.
Diamond L.C., Jacobs EA. Chapter 2: Teaching Health Professionals about Language Barriers. In: Hernandez C, editor. Language Teaching: Techniques, Developments and Effectiveness. Hauppauge, NY: Novascience. 2010; 27-49.
Stoll, A.L., Pillay, S.S., Diamond, L.C., Workum, S.B., Cole, J.O. Reply to Letter to the Editor #1548: Methylphenidate and SSRI Induced Sexual Side Effects. Journal of Clinical Psychiatry, 1996;57: 548.
Stoll, A.L., Pillay, S.S., Diamond, L.C., Workum, S.B., Cole, J.O. Methylphenidate Augmentation of Selective Serotonin Reuptake Inhibitors: A Case Series. Journal of Clinical Psychiatry, 1996;57:2, 72-76.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more